4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-24-014146
PRESIDENT AND CEO gave up 7,102 shares (to pay taxes)
- PRESIDENT AND CEO acquired 29,345 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin PRESIDENT AND CEO | 2024-05-20 | Option exercise | +6,758 | 5,310,669 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-05-20 | Shares withheld for taxes | −1,601 | $5.96 | $9,542 | 5,309,068 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2024-05-20 | Option exercise | +7,854 | 5,316,922 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-05-20 | Shares withheld for taxes | −1,913 | $5.96 | $11,401 | 5,315,009 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2024-05-20 | Option exercise | +14,733 | 5,329,742 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-05-20 | Shares withheld for taxes | −3,588 | $5.96 | $21,384 | 5,326,154 | D |
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2024-05-20 | Option exercise · Restricted Stock Units | −6,758 | 45,062 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-05-20 | Option exercise · Restricted Stock Units | −7,854 | 133,523 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-05-20 | Option exercise · Restricted Stock Units | −14,733 | 338,873 | D | ||
Loading xslF345X05/form4-05222024_100540.xml…